Rechercher

Philippe Deruelle, Loïc Sentilhes, Louise Ghesquière, Raoul Desbrière, Guillaume Ducarme, Luisa Attali, Annic Jarnoux, France Artzner, Audrey Tranchant, Thomas Schmitz, Marie-Victoire Sénat. June 2024, page 86

COPD exacerbations

COPD exacerbations, characterized by an acute worsening of dyspnea and/or cough and sputum volume beyond daily variations, are a public health issue because of their frequency, the number of...

Simon Valentin, Bruno Ribeiro Baptista, Ari Chaouat, François Chabot \. June 2024, page 96

What are the indications for corticosteroid therapy in COPD?

In stable state chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICS) should be used in case of frequent exacerbation only, associated with long-term bronchodilators including...

Gaëtan Deslée. June 2024, page 100

Localized or generalized edema of the lower limbs

Stéphane Vignes, Marie Essig. June 2024, page 105

Developments in forensic medicine: the example of Haute-Normandie

Bernard Proust. June 2024, page 115

The metamorphoses of sleep

Vahe Mournet. June 2024, page 3

Health effects of alcohol: untangling the truth from the false!

Daily alcohol consumption is associated with an increased risk of death, even at low doses. However, it remains high in France, where a large proportion of the population consumes alcohol in excess...

Catherine Hill. October 2024, page 6

When should short-term antibiotic therapy be chosen?

Reducing antibiotic exposure by shortening treatment duration is a public health priority that could mitigate the emergence of bacterial resistance, minimize adverse effects, and lower costs....

Emma D'Anglejan, Frédérique Bouchand, Aurélien Dinh. October 2024, page 14

Infectious endocarditis: from epidemiology to prevention

The incidence of infective endocarditis is estimated between 30 and 80 cases per million inhabitants and per year in the general population in industrialized countries. It is heterogeneous and...

Bernard Iung. October 2024, page 22

Infectious endocarditis: strategy for diagnosis

The diagnosis of infective endocarditis is often difficult because the clinical presentations are very heterogeneous. Epidemiology has evolved with more acute forms, different microorganisms, and...

Anne Bernard, Nicolas Chane-Sone, Fanny Dion, Adrien Lemaignen. October 2024, page 27

Treatment of infective endocarditis

Patients with infective endocarditis (IE) are taken care for by multidisciplinary teams. The treatment consists of antibiotic therapy initiated early, adapted to the responsible germ and...

Florent Arregle. October 2024, page 35

Complications of infective endocarditis

The high in-hospital mortality of patients with infective endocarditis (about 20%) is mainly due to its complications. These complications are essentially of cardiac, neurological, and infectious...

Faouzi Trojette, Chloé Di Lena, Yohann Bohbot, Dan Rusinaru, Christophe Tribouilloy. October 2024, page 43

European registry of infectious endocarditis

The EURO-ENDO registry was initiated in 2018. Its objectives were to assess the epidemiological, clinical, bacteriological, and prognostic features of infective endocarditis. Initially only...

Gilbert Habib. October 2024, page 51

Infectious endocarditis and cancers: results of the EURO-ENDO registry

Bernard Cosyns, Gilbert Habib. October 2024, page 55

Infectious endocarditis: 8 key messages

Gilbert Habib. October 2024, page 57

Mask tackle in apnea

Guillaume Janet-Maitre, Arnaud Druelle. October 2024, page 59

Major hypereosinophilia associated with Fasciola hepatica distomatosis

Thierry Carmoi, Magali Billhot, Marc Aletti. October 2024, page 60

Coronary sinus rhythm

Matthieu Bellakehal, Yoan Laine. October 2024, page 62

Living with… the after-effects of burns

Marc Chaouat. October 2024, page 63

Sweeteners: recent recommendations for health

Intense sweeteners are compounds with a higher sweetening power than sugar. Their use has grown in industrial products and at home to reduce sugar intake, which is associated to health risks. In...

Mélanie Deschasaux-Tanguy, Bernard Srour, Mathilde Touvier. October 2024, page 66

Sargassum seaweed assaults the French West Indies

Since 2011, Martinique and the islands of Guadeloupe have been affected by repeated groundings, culminating in an exceptional wave in 2018. While the sargassum ( Sargassum natans and S. fluitans )...

Dabor Resiere, Jonathan Florentin, Rémi Nevière. October 2024, page 71

Living with... neurofibromatosis type 2

Michel Kalamarides. October 2024, page 77

Renal colic management

Renal colic is a common reason for consultation or emergency room visit. In most of the cases, it is caused by the migration of a urinary calculus and the resulting ureteral obstruction. In 2022...

Gauthier Raynal, Christophe Alméras. October 2024, page 80

Bipolar disorder in adolescents and adults

Christophe Lançon. October 2024, page 87

Bipolar depression, suicide and the prescription of antidepressants

Christophe Lançon. October 2024, page 94

Medical anthropology: the contribution of Éric de Rosny, "the African Jesuit"

Jacqueline Faure, Adrienne Lerner. October 2024, page 95

Nutri-Score: when economic lobbies accuse academic researchers of a conflict of interest with... science!

Serge Hercberg, Pilar Galan, Mélanie Deschasaux-Tanguy, Mathilde Touvier. December 2024, page 6

Iconodiagnosis, the art of semiology

Philippe Charlier. December 2024, page 10

Antimicrobial resistance in human and veterinary medicine: where are we?

In both human and veterinary medicine, the evolution of antimicrobial resistance is worrying for some antibiotics or bacterial species, but less for others. In humans and animals, the picture for...

Laurence Armand-Lefèvre, Jean-Yves Madec. December 2024, page 14

Risk of acquiring antibiotic-resistant bacteria and travel

The continuing expansion of international tourism increases the opportunities of contact with diverse epidemiological environments, leading to both a risk of bacterial acquisition or infection for...

Paul-Henri Consigny, Laurence Armand-Lefèvre. December 2024, page 20

Shortened antimicrobial therapy duration

Antibiotic treatment durations represent an important field of current clinical research. Indeed, shortening antibiotic duration during bacterial pathologies has several advantages: reducing the...

Aurélien Dinh, Bernard Castan. December 2024, page 26

Hospital antimicrobial stewardship

Hospital antimicrobial stewardship programs have been thought to preserve the efficacy of antimicrobials for the treatment of human and animal bacterial infections. They must apply for every...

Philippe Lesprit, Patricia Pavese. December 2024, page 34

How to read new antimicrobial susceptibility testing results?

Antimicrobial susceptibility testing (AST) results (formerly 'susceptible', 'intermediate' and 'resistant') are now expressed with the new susceptibility categories 'susceptible, standard dosing...

Frédéric Schramm, Raphaël Lepeule. December 2024, page 40

Phage therapy: where do we stand?

Bacteriophages, discovered at the beginning of the 20th century by Félix d'Hérelle, are viruses that infect and destroy bacteria. Unlike antibiotics, phages are specific to a given bacterial...

Alexandre Bleibtreu, Sylvain Diamantis. December 2024, page 46

New challenge in antibacterial treatments: 10 key messages

Pierre Tattevin. December 2024, page 51

Result : 353

Pathophysiological hypothesis and diagnosis of insomnia disorder

Sleep debt epidemic

Insomnia/sleep apnea: COMISA

Insomnia and sleep environment

Insomnia and psychiatric disorders

Behavioral management of insomnia

Sleep centers: from diagnosis to care

Pharmacotherapies for insomnia

Insomnia: 10 key messages

Pruritic rash caused by sandflies

Vesicant contact with cantharides

Hamstring hematoma

Bilateral gonalgias revealing a parathyroid adenoma

Living with… neurofibromatosis type 1

Living with… psoriasis

Nausea and vomiting in pregnancy